Also did the FDA recommend taking the trial overseas because how bad it is in other countries? Doubtful, but I’m curious as to that as well.

I did hear NP say they can grant EUA based on the data overseas or he eluded to it last CC. Then if the trials good I’m assuming we would do another In U.S. and have a BLA ready to go for approval.